medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 588

<< Back Next >>

Rev Med Cos Cen 2009; 66 (588)

Estudio de un meta análisis sobre la eficacia del tratamiento para erradicación de helicobacter pylori en niños

Campos NC
Full text How to cite this article

Language: Spanish
References: 10
Page: 219-223
PDF size: 489.72 Kb.


Key words:

No keywords

ABSTRACT

Approximately 15% of H. pylori infected children suffer gastroduodenal ulcer. Several meta-analyses assessing the efficacy of anti-H. pylori treatment in adults have been published but a comparable meta-analysis in children is lacking. To summarize the efficacy of treatments aimed at eradicating H. pylori in children and to identify variation in treatment efficacy across studies. Was searched Medline, reference lists from published study reports, and conference proceedings for anti-H. pylori treatment trials in children. Weighted meta-regression models were used to find sources of variation in efficacy. Eighty studies (127 treatment arms) with 4436 children were included. Overall, methodological quality of these studies was poor with small sample sizes and few randomized-controlled trials. The efficacy of therapies varied across treatment arms, treatment duration, method of post-treatment assessment and geographic location. Among the regimens tested, 2–6 weeks of nitroimidazole and amoxicillin, 1–2 weeks of clarithromycin, amoxicillin and a proton pump inhibitor, and 2 weeks of a macrolide, a nitroimidazole and a proton pump inhibitor or bismuth, amoxicillin and metronidazole were the most efficacious in developed countries. Before worldwide treatment recommendations are given for eradication of H. pylori, additional well-designed randomized placebo-controlled pediatric trials are needed, especially in developing countries where both drug resistance and disease burden is high.


REFERENCES

  1. Behrman R., Nelson Compendio de Pediatría, Mc Graw-Hill 4ª ed., 2003, Colombia, pp 540-541.

  2. Braunwald E., Harrison Principios de Medicina Interna 15 ed., Mc Graw-Hill, Mexico, 2002, pp 1926-1945.

  3. Cruz-Hernández, Tratado de pediatría, 2007, editorial Océano, Barcelona, pp 1102-1104.

  4. Feldman M., Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 8th ed. 2006, Saunders, Philadelphia, cap 48 pp 1049- 1062.

  5. Hardman J., Goodman & Gilman Las Bases Farmacológicas de la Terapéutica 10 ed., Mc Graw-Hill, Mexico, 2003, pp 1031-1033.

  6. Khurana R. et al, Meta-analysis: Helicobacter pylori Eradication Treatment Efficacy in Children. Aliment Pharmacol Ther. 2007;25(5):523-535.

  7. McMillan J., Oski’s Pediatrics: Principles and Practice, 3rd Ed.1999: Lippincott Williams & Wilkins Publishers.pp 1605-1610

  8. North American Society for Pediatric Gastroenterology and Nutrition; Helicobacter pylori Infection in Children: Recommendations for Diagnosis and Treatment, Journal of Pediatric Gastroenterology and Nutrition 2000. 31:490–497.

  9. Rivera P. et al. H. pylori en Niños atendidos en el Hospital Nacional de Niños. Acta Gastroenterológica Latinoamericana. 2003;33(3):159-63.

  10. Saperas E. et al, Farreras Medicina Interna 13 ed. 2000, Barcelona, pp 93-105.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2009;66